Custom Search

Japanese Encephalitis Vaccine Clears Safety Tests

Category: Drug News RSS
Friday, November 30, 2007 at 6:16:17 PM
Bookmark and Share     Font Size 
Japanese Encephalitis Vaccine Clears Safety Tests - Medindia
Bookmark and Share   Print this page Print   Comments Comments  
A prototype vaccine against Japanese encephalitis, a viral disease endemic in Southeast Asia and parts of South Asia, is safe and triggers a good immune response against the pathogen, a study to be published on Saturday says.

Transmitted through mosquito bites, Japanese encephalitis can cause fever, blinding headaches, neck stiffness and convulsions and in a fifth of cases is fatal.

The test vaccine, made by a Scottish subsidiary of Intercell AG, an Austrian-headquartered company, was tested on 867 adults in the United States, Britain and Austria.

Response from antibodies -- the frontline troops in the body's immune system -- was twice that for a existing vaccine against the disease and side effects "were generally mild," according to the study, which appears in The Lancet.

Around 50,000 cases of Japanese encephalitis occur each year, mainly in children under 10, according to the US Centers for Disease Control (CDC).

An outbreak in northern India this year claimed more than 300 lives. The natural reservoir for the virus is pigs and wild birds.

The disease has been mainly fought using a vaccine that is derived from the brains of mice that have been infected with the virus. The virus is then killed -- "inactivated" -- using chemicals before it is introduced into the body.

The problem, though, is that this vaccine is expensive, difficult to produce, needs three doses and has been associated with bad but rare, allergic responses.
Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment
* Your comment can be maximum of 2500 characters
Notify me when reply is posted   

Related Links

Medindia on Chinese Delegation Meets Health Minister Regarding Japanese Encephalitis Vaccine Supply
The CNBG is Government owned, the largest vaccine manufacturer and supplier in China. Among other things, the delegation discussed the supply live of JE vaccine in order to protect Indian children from Japanese Encephalitis.

Read More...

For More Information
Intercell to Begin Phase II JE Vaccine Trials in India
Encephalitis outbreak has claimed 300 lives in India since July

Medindia Health Network

Tweet this page Share this page
500 + Health news categories
Latest Health News From Leading Resources
Updated every 30 minutes
Japanese Encephalitis
Complete Medindia Resources
World Diabetes Day
Select a News Category
News Archive
Date :
Category :
Keyword :
Medindia on Facebook
Feedback  Advanced Search
Last Updated - - Designed & Content Managed by Medindia Health Network Pvt Ltd. Hosted & Technical Support by FrontPoint Systems
DisclaimerThe contents of this site are for informational purposes only. Always seek the advice of a qualified physician for any doubts.
To Read full Disclaimer Click Here!
Best viewed with resolution 1024x768 px.
Advertise with us |  Medindia Copyright |  Privacy Policy | Terms of Use |  © All Rights Reserved 1997 - 2009